Reckitt Benckiser Group (LON:RKT) Shares Up 0.2% – Still a Buy?

Shares of Reckitt Benckiser Group plc (LON:RKT) traded up 0.2% during trading on Wednesday . The stock traded as high as GBX 4,898.10 ($65.68) and last traded at GBX 4,898.10 ($65.68). 1,770,592 shares were traded during mid-day trading, a decline of 62% from the average session volume of 4,657,759 shares. The stock had previously closed at GBX 4,886 ($65.52).

Reckitt Benckiser Group Trading Up 0.2%

The stock’s 50 day simple moving average is GBX 4,944.55 and its two-hundred day simple moving average is GBX 4,983.73. The stock has a market capitalization of £33.42 billion, a PE ratio of 22.41, a PEG ratio of 1.10 and a beta of 0.09. The company has a debt-to-equity ratio of 110.26, a current ratio of 0.69 and a quick ratio of 0.46.

Reckitt Benckiser Group (LON:RKT) last posted its quarterly earnings data on Thursday, March 6th. The company reported GBX 349.70 ($4.69) EPS for the quarter. Reckitt Benckiser Group had a return on equity of 18.70% and a net margin of 10.78%. On average, sell-side analysts expect that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.

Reckitt Benckiser Group Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, April 10th will be paid a dividend of GBX 121.70 ($1.63) per share. This is an increase from Reckitt Benckiser Group’s previous dividend of $80.40. The ex-dividend date of this dividend is Thursday, April 10th. This represents a dividend yield of 2.38%. Reckitt Benckiser Group’s dividend payout ratio is presently 89.69%.

Insider Buying and Selling at Reckitt Benckiser Group

In related news, insider Kris Licht sold 3,799 shares of Reckitt Benckiser Group stock in a transaction that occurred on Friday, March 21st. The shares were sold at an average price of GBX 5,177 ($69.42), for a total value of £196,674.23 ($263,744.44). Insiders own 0.05% of the company’s stock.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.